iShares NASDAQ Biotechnology Index logo SG Americas Securities LLC increased its stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 28.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned …
bluebird bio logo Jennison Associates LLC trimmed its holdings in bluebird bio Inc (NASDAQ:BLUE) by 18.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 540,697 shares of the biotechnology company’s stock after selling …
iShares NASDAQ Biotechnology Index logo SG Americas Securities LLC increased its stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 28.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned …
This post is part of BIO’s yearlong, bi-weekly series called Flashback Friday, highlighting newsletter stories from BIO’s past. To learn more about BIO’s history and our 25th Anniversary visit our interactive historical timeline. Reprinted from BIONews, September/October 1993 REFORMING AMERICA’S HEALTH CARE SYSTEM: FIRST ASK THE RIGHT QUESTIONS By G. Kirk Raab, Chairman, Biotechnology Industry …
Read Article: Flashback Friday: Historical Perspective on Health Care Reforms
17 comments, 223 likes on Facebook, and 88 retweets. You’re writing stuff, and people are reading it. They’re clicking your links and arriving at your blog. Your efforts are finally paying off with a steady stream of traffic. We’re not going to focus on the importance of a business blog. You know it’s crucial to …
Read Article: How to Convert Blog Readers to Leads
Editor’s Note: As part of BIO’s 25th Anniversary celebration we will be spotlighting biotechnology innovations that have made a major impact over the past 25 years. This “Innovation Series” will publish on the 25th of every month throughout 2018. We kick-off this month with personalized medicine. One size does not fit all when it comes to medicine. …
Read Article: Biotechnology in Action: How Innovation is Having an Impact in Personalized Medicine
More than a decade ago, the NIH Roadmap and the FDA Critical Path Report brought significant public attention and new programmatic efforts to advance sponsored and translational research. These programs act as bridges between the promise of bioscience discoveries and the advancement of new biomedical innovations to improve the lives of patients. Of particular importance for accelerating …
Read Article: The Value of Academic-Industry Partnerships
Jan 23 (Reuters) – Puma Biotechnology Inc said on Tuesday a European regulatory panel indicated it was unlikely to provide a positive opinion on the company’s breast cancer drug, sending its shares down 30 percent. The setback comes six months after the U.S. Food and Drug Administration …
Here’s a statistic you might not have known: an estimated 700,000 people die each year due to the growing number of infections resistant to treatment. Known as antimicrobial resistance (AMR), this “silent killer” and looming public health threat has severe social and economic consequences that could have a lasting impact on families, individuals and communities …
Read Article: Combating Antimicrobial Resistance